Skip to main content

Advertisement

Figure 3 | BMC Medical Genetics

Figure 3

From: Assessment of the feasibility of exon 45–55 multiexon skipping for duchenne muscular dystrophy

Figure 3

Western blot analysis of the exon 48–50 deleted cells. No dystrophin could be observed in non-treated (NT) or treated myotubes. Each treatment was performed in duplo. Myosin staining was used as a loading control and to confirm that myogenicity was sufficient to allow dystrophin expression (data not shown). Different dilutions of protein from control cells were used as a positive control (right panel). Levels of 1% of the normal levels were detectable.

Back to article page